Retina Discovery Group

Research group at @Moorfields Eye Hospital and @UCLeye.
Ophthalmology + data science + basic science
= breakthroughs.

[Retina Discovery Group @RetinaDiscovery]

Out now on @BMJ_Ophth 📣
Our study, led by @abraham_olvera1, analysing the prevalence of visual impairment compared to certification of visual impairment (CVI) in patients with diabetic retinopathy (DR).

https://t.co/AdzXDc8CVc

[Retina Discovery Group @RetinaDiscovery]

🔬 New Research Alert:
A new publication led by Claudia Liang Peng. The first report of bilateral non-vasogenic cystoid macular oedema and outer retinal columnar abnormalities (ORCA) in the context of dense deposit disease:
https://t.co/1vV2mPeNFF

[Retina Discovery Group @RetinaDiscovery]

📣Recently published - A Deep Learning Framework for the Detection and Quantification of Reticular Pseudodrusen and Drusen on Optical Coherence Tomography.

This work is part of our initiative to unlock the mystery of RPD using #AI. More to come soon!

[Roy Schwartz, MD, PhD @royschwartz]

I'm very proud to announce the recent publication of this paper on @ARVOtvst: https://t.co/YEVKLf7kdb
This is both the first publication out of my PhD and a breakthrough in #RPD research. @Moorfields @MoorfieldsBRC @cdt_ai_health

[Retina Discovery Group @RetinaDiscovery]

We have found a marked under-registration of visual impairment of 84% in patients with DR at the largest centre for ophthalmic treatment in England.

[Retina Discovery Group @RetinaDiscovery]

Out now on @BMJ_Ophth 📣
Our study, led by @abraham_olvera1, analysing the prevalence of visual impairment compared to certification of visual impairment (CVI) in patients with diabetic retinopathy (DR).

https://t.co/AdzXDc8CVc

[Retina Discovery Group @RetinaDiscovery]

Certification of visual impairment (CVI) is a valuable tool to provide assistance for patients and also to measure the causes and rates of visual disability in the UK. Certification is voluntary and must be started by an ophthalmologist.

[Retina Discovery Group @RetinaDiscovery]

@caisaram @PhilippLMuller Yes! Definitely possible. It would require training a new algorithm but the technology is similar.

[Roy Schwartz, MD, PhD @royschwartz]

I was honoured to (virtually) speak this morning at the #EURETINA2022 conference about the results of our study on reticular pseudodrusen and plans for the future. Thank you @EURETINA for supporting this important endeavour!

[EURETINA @EURETINA]

It is of great importance to detect dry AMD early, as treatments aim to slow down the progression rather than reversing it. Atrophy begins outside the fovea; a 25-50% progression reduction rate can delay foveal encroachment for years. @adnan_tufail1 #EURETINA2022

[Retina Discovery Group @RetinaDiscovery]

This important study, led by @PhilippLMuller, @adnan_tufail1, @aaronylee, Yuka Kihara, @abraham_olvera1, Katie Williams, @AlasdairWarwick, and Cathy Egan offers new directions for future myopia and macula research. 🧵 4/4

[Retina Discovery Group @RetinaDiscovery]

📣Out now on @ARVOiovs!
Using an automated machine learning model, we analysed the macular curvature on OCT in 65,023 subjects from the @uk_biobank. 🧵 1/4
https://t.co/wsnI9dVPTy

[Retina Discovery Group @RetinaDiscovery]

We also investigated associations for dome-shaped macular configuration, and showed that it is significantly more common than reported before, especially in emmetropic and hypermetropic eyes. 🧵 3/4

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

How common is common?
New insights into Macular Curvature and Dome-Shaped Configuration based on data from the unique UK Biobank. This may open new fields to future #myopia and #macula research! @RetinaDiscovery https://t.co/b8kn8gm4pT

[Roy Schwartz, MD, PhD @royschwartz]

I'll be presenting our deep learning framework for the detection and quantification of RPD and drusen at #arvo2022 on Wednesday. Come say hi!

[Retina Discovery Group @RetinaDiscovery]

Our recent publication is now on @BMJ_Open, highlighting the importance of patient care even during a pandemic to preserve functional vision. Brilliant work by @AlasdairWarwick and others! https://t.co/0sLcLHETik

[Abraham Olvera @abraham_olvera1]

Now published:
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model https://t.co/EA25VmGW0f
Well done @AlasdairWarwick, Darren Thomas. @RetinaDiscovery

[Retina Discovery Group @RetinaDiscovery]

New publication now in preprint - a deep learning framework for the identification and quantification of RPD and drusen on OCT scans! Unlocking the mystery of RPD using #AI

https://t.co/7zZ2QsJejY

[Roy Schwartz, MD, PhD @royschwartz]

📣I'm delighted to report that our paper describing the first #AI framework to identify and quantify drusen and #RPD on OCT scans is now in preprint! @RetinaDiscovery @uk_biobank @Moorfields @MoorfieldsBRC @cdt_ai_health
https://t.co/1kfVyYJm1Y

[Retina Discovery Group @RetinaDiscovery]

Visit our latest blog post for a sneak preview of our deep learning model. Developed by @royschwartz and funded by @EURETINA, It is the first model to accurately detect and quantify drusen and reticular pseudodrusen with high accuracy. https://t.co/tiu09qFjH2 @Moorfields